# Furosemide vs Placebo in Severe Preeclampsia Postpartum

Study · id `cardio:ct-nct07648251` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07648251](<https://clinicaltrials.gov/study/NCT07648251>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07648251

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 186 participants.

## Technical summary

Registry record NCT07648251. Randomized; triple masking; primary purpose treatment. Start 2026-11-02 (anticipated); primary completion 2027-03-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 186 participants (planned count; ClinicalTrials.gov record NCT07648251, source copy `cardio:ctgov-nct07648251-2026-11-05`, retrieved 2026-11-18)
- Planned start: 2026-11-02 (anticipated) (ClinicalTrials.gov record NCT07648251, source copy `cardio:ctgov-nct07648251-2026-11-05`, retrieved 2026-11-18)
- Primary completion: 2027-03-31 (anticipated) (ClinicalTrials.gov record NCT07648251, source copy `cardio:ctgov-nct07648251-2026-11-05`, retrieved 2026-11-18)
- Completion: 2027-03-31 (anticipated) (ClinicalTrials.gov record NCT07648251, source copy `cardio:ctgov-nct07648251-2026-11-05`, retrieved 2026-11-18)
- Countries: Honduras (ClinicalTrials.gov record NCT07648251, source copy `cardio:ctgov-nct07648251-2026-11-05`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07648251-2026-11-05`, retrieved 2026-11-18)

## The registry's words

- Brief title: Furosemide vs Placebo in Severe Preeclampsia Postpartum
- Acronym: FUROPE
- Condition: Severe Preeclampsia
- Intervention (Drug): Furosemide
- Intervention (Drug): Folic Acid 5 MG
- Lead sponsor: Universidad Nacional Autonoma de Honduras
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

## Provenance

Content hash: ea80634c2c3afb2cfe6f1414c62aa6825b5a4e57372d01a0d4632ccf22f6d4a3
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
